High CD34 surface expression in BCP‐ALL predicts poor induction therapy response and is associated with altered expression of genes related to cell migration and adhesion
Open Access
- 7 April 2022
- journal article
- research article
- Published by Wiley in Molecular Oncology
- Vol. 16 (10) , 2015-2030
Abstract
Minimal residual disease (MRD) constitutes the most important prognostic factor in B‐cell precursor acute lymphoblastic leukemia (BCP‐ALL). Flow cytometry is widely used in MRD assessment, yet little is known regarding the effect of different immunophenotypic subsets on outcome. In this study of 200 BCP‐ALL patients, we found that a CD34‐positive, CD38 dim‐positive, nTdT dim‐positive immunophenotype on the leukemic blasts was associated with poor induction therapy response and predicted an MRD level at the end of induction therapy (EOI) of ≥ 0.001. CD34 expression was strongly and positively associated with EOI MRD, whereas CD34‐negative patients had a low relapse risk. Further, CD34 expression increased from diagnosis to relapse. CD34 is a stemness‐associated cell‐surface molecule, possibly involved in cell adhesion/migration or survival. Accordingly, genes associated with stemness were overrepresented among the most upregulated genes in CD34‐positive leukemias, and protein–protein interaction networks showed an overrepresentation of genes associated with cell migration, cell adhesion, and negative regulation of apoptosis. The present work is the first to demonstrate a CD34‐negative immunophenotype as a good prognostic factor in ALL, whereas high CD34 expression is associated with poor therapy response and an altered gene expression profile reminiscent of migrating cancer stem‐like cells.Keywords
Funding Information
- European Regional Development Fund
- Børnecancerfonden (2019‐5934, 2020‐5769)
- Kræftens Bekæmpelse (R‐257‐A14720)
This publication has 74 references indexed in Scilit:
- 5T4 oncofetal antigen is expressed in high risk of relapse childhood pre-B acute lymphoblastic leukemia and is associated with a more invasive and chemotactic phenotypeLeukemia, 2012
- Robo4 Cooperates with Cxcr4 to Specify Hematopoietic Stem Cell Localization to Bone Marrow NichesCell Stem Cell, 2011
- A framework for oligonucleotide microarray preprocessingBioinformatics, 2010
- Rearrangement of CRLF2 is associated with mutation of JAK kinases, alteration of IKZF1, Hispanic/Latino ethnicity, and a poor outcome in pediatric B-progenitor acute lymphoblastic leukemiaBlood, 2010
- Prognostic significance of CD20 expression in adults with de novo precursor B-lineage acute lymphoblastic leukemiaBlood, 2009
- Quantitative analysis of minimal residual disease predicts relapse in children with B-lineage acute lymphoblastic leukemia in DFCI ALL Consortium Protocol 95-01Blood, 2007
- Prognostic significance of CD20 expression in childhood B-cell precursor acute lymphoblastic leukemiaBlood, 2006
- A Stem Cell Molecular SignatureScience, 2002
- "Stemness": Transcriptional Profiling of Embryonic and Adult Stem CellsScience, 2002
- Checking the Cox model with cumulative sums of martingale-based residualsBiometrika, 1993